A new research has revealed that men with moderate baldness affecting both the front and the crown of their head at the age of 45 have 40 percent higher risk of developing aggressive prostate cancer later in life than their non-bald counterparts.
Typically, prostate cancer occurs more frequently as men age into their 70s or 80s, but a US-based analysis has found that the number of younger men diagnosed with prostate cancer has increased nearly six-fold in the last 20 years.
The presence of chronic inflammation in benign prostate tissue has been found to be linked with high-grade, or aggressive, prostate cancer, and this association was found even in those with low prostate-specific antigen (PSA) levels.
In a discovery that can help devise a novel diagnostic approach for aggressive prostate cancer, scientists have found a link between the aggressiveness of the disease and the accumulation of a compound produced when cholesterol is metabolised in cells.
Researchers at the Cincinnati Cancer Center have shown that levels of bisphenol A (BPA) in men`s urine could be a marker of prostate cancer and that low levels of BPA exposure can cause cellular changes in both non-malignant and malignant prostate cells.
A new study by Indian origin researcher has revealed that the synthesis of the most active component of grape seed extract, B2G2, encourages the cell death known as apoptosis in prostate cancer cells while leaving healthy cells unharmed.